In almost 90% of ALK-positive (ALK+) ALCL, the translocation fuses the ALK kinase gene to the nucleophosmin (NPM) gene at chromosome locus 5q35 and results in the expression of an oncogenic fusion protein, NPM-ALK (Fig. 1)1–4. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.